Peripheral Arterial Disease Disease length
Item
subjects with peripheral arterial disease for more than 6 months.
boolean
C1704436 (UMLS CUI [1,1])
C0872146 (UMLS CUI [1,2])
Claudication Secondary to ARTERIOSCLEROSIS OF LOWER EXTREMITY | Ankle brachial pressure index Leg | Ankle brachial pressure index Both legs | Intervention Previous Peripheral Arterial Disease
Item
male or female with claudication secondary to lower extremity atherosclerotic arterial disease. (with limited ic but not incapacitated for walking on the level) confirmed with ankle/brachial pressures< or = to 0.9 in one or both legs) or who have had a previous intervention for peripheral arterial disease.
boolean
C1456822 (UMLS CUI [1,1])
C0175668 (UMLS CUI [1,2])
C0518957 (UMLS CUI [1,3])
C1276055 (UMLS CUI [2,1])
C1140621 (UMLS CUI [2,2])
C1276055 (UMLS CUI [3,1])
C0230446 (UMLS CUI [3,2])
C0184661 (UMLS CUI [4,1])
C0205156 (UMLS CUI [4,2])
C1704436 (UMLS CUI [4,3])
Age
Item
over 40 years old
boolean
C0001779 (UMLS CUI [1])
Protocol Compliance
Item
able to comply with protocol requirements
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
able to provide informed consent
boolean
C0021430 (UMLS CUI [1])
Antiplatelet Agents Dosage Stable
Item
subjects taking anti-platelet therapy medication must be on a stable dose for 3 months prior to as well as during the study.
boolean
C0085826 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Hypolipidemic Agents Dosage Stable
Item
subjects taking lipid lowering medication must be on a stable dose for 3 months prior to as well as during the study.
boolean
C0086440 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Rest pain Ischemic Limbs | Ulceration | Gangrene
Item
patients with ischemic rest pain in limbs, ulceration, or gangrene.
boolean
C0234253 (UMLS CUI [1,1])
C0475224 (UMLS CUI [1,2])
C0015385 (UMLS CUI [1,3])
C3887532 (UMLS CUI [2])
C0017086 (UMLS CUI [3])
Condition Preventing Walking Treadmill
Item
at baseline, any condition that prevents walking on a treadmill.
boolean
C0348080 (UMLS CUI [1,1])
C1292733 (UMLS CUI [1,2])
C0080331 (UMLS CUI [1,3])
C0184069 (UMLS CUI [1,4])
Hemorrhage Major
Item
history of major bleeding.
boolean
C0019080 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
Intestinal Disease | Crohn Disease | Celiac Disease | Peptic Ulcer | Irritable Bowel Syndrome | Diverticulosis
Item
patients with bowel disease (including crohn's disease, celiac disease, peptic ulcer disease, irritable bowel syndrome and diverticulosis).
boolean
C0021831 (UMLS CUI [1])
C0010346 (UMLS CUI [2])
C0007570 (UMLS CUI [3])
C0030920 (UMLS CUI [4])
C0022104 (UMLS CUI [5])
C1510475 (UMLS CUI [6])
Life Expectancy | Risk factors cardiac high | Status post Ischemic cardiomyopathy | Status post Diabetic Cardiomyopathy | Cardiac ejection fraction | Angina Pectoris CCS Grading Scale Class | Patient need for Coronary revascularisation
Item
patients with an estimated life expectancy less than 2 years and with high baseline cardiac risk (post ischemic or diabetic cardiomyopathy with ef<40%, canadian cardiovascular society class 3 or 4 angina or need for coronary revascularization procedures).
boolean
C0023671 (UMLS CUI [1])
C3693584 (UMLS CUI [2])
C0231290 (UMLS CUI [3,1])
C0349782 (UMLS CUI [3,2])
C0231290 (UMLS CUI [4,1])
C0853897 (UMLS CUI [4,2])
C0232174 (UMLS CUI [5])
C0002962 (UMLS CUI [6,1])
C1879987 (UMLS CUI [6,2])
C0686904 (UMLS CUI [7,1])
C0877341 (UMLS CUI [7,2])
RENAL FAILURE MODERATE | Kidney Failure Severe
Item
moderate to severe renal failure.
boolean
C0748307 (UMLS CUI [1])
C0035078 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Supplements | Exception Prescription Supplements
Item
subjects that are on supplements other that those prescribed by their clinician for the entire duration of the study.
boolean
C0242295 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0033080 (UMLS CUI [2,2])
C0242295 (UMLS CUI [2,3])
Fish Limitation | Fish Meal Quantity per week
Item
fish limitations (no more than 2 fish meals per week)
boolean
C4521129 (UMLS CUI [1,1])
C0449295 (UMLS CUI [1,2])
C4521129 (UMLS CUI [2,1])
C1998602 (UMLS CUI [2,2])
C1265611 (UMLS CUI [2,3])
C0332174 (UMLS CUI [2,4])
Hypersensitivity Gluten
Item
gluten allergy
boolean
C0020517 (UMLS CUI [1,1])
C2362561 (UMLS CUI [1,2])
Hypersensitivity Investigational New Drugs Ingredient | Hypersensitivity Placebo Ingredient
Item
subjects with allergies to any ingredient in the study product or placebo.
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C1550600 (UMLS CUI [1,3])
C0020517 (UMLS CUI [2,1])
C1696465 (UMLS CUI [2,2])
C1550600 (UMLS CUI [2,3])
Operative Surgical Procedures Planned
Item
patients who plan to undergo surgery during the course of the trial.
boolean
C0543467 (UMLS CUI [1,1])
C1301732 (UMLS CUI [1,2])